Breaking News

AREVA Med Launches New Production Facility

Will produce lead-212 for Phase I trial

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

AREVA Med has launched its Maurice Tubiana facility located at Bessines-sur-Gartempe, France, following administrative authorizations and completing technical testing. The facility began production to extract and purify lead-212 for medical use.   Lead-212 is a rare metal used in the development of treatments for certain cancers that do not respond to other conventional methods. Nuclear medicine is dependent on the availability of high purity isotopes and the production at the Maurice Tubiana fa...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters